| ID: | 127 | |
|---|---|---|
| Name: | Compound 127 | |
| Description: | Original numeration in publication: 11 | |
| Labels: | Test_set, Thiazolidine‐2, 4‐dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C19H14ClN3O4S/c20-13-5-1-11(2-6-13)9-15-18(26)23(19(27)28-15)10-16(24)22-14-7-3-12(4-8-14)17(21)25/h1-9H,10H2,(H2,21,25)(H,22,24)/b15-9- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.55 |
El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491 |
| 6.49353 |
Eq1: VEGFR-2 inhibition (Data used to validate model) |